← Back to Search

Behavioral Intervention

Exercise for Prostate Cancer

N/A
Recruiting
Led By Dong-Woo Kang, PhD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (week 1) and post-intervention (week 18)
Awards & highlights

Study Summary

This trial will assess if exercise can slow prostate cancer progression in Black men on active surveillance.

Who is the study for?
This trial is for Black men over 18 with early-stage prostate cancer who are on active surveillance. They should be able to visit Dana-Farber Cancer Institute, understand English, sign consent forms, and have medical clearance to exercise. They must do less than 60 minutes of moderate-to-vigorous exercise weekly and not plan any invasive treatments for the next 16 weeks.Check my eligibility
What is being tested?
The REMOVE Trial tests if a home-based, virtual high-intensity interval training (HIIT) program can slow prostate cancer progression in participants. It's a supervised 16-week aerobic exercise regimen designed specifically for this study.See study design
What are the potential side effects?
While specific side effects aren't listed for this type of non-drug intervention, general risks may include muscle soreness, fatigue or injury from physical activity. Participants will be monitored for any adverse reactions related to the exercise program.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (week 1) and post-intervention (week 18)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (week 1) and post-intervention (week 18) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Prostate-Specific Antigen (PSA) Level
Secondary outcome measures
Cardiorespiratory Fitness
Fear of Cancer Progression Assessment
Health-Related Quality of Life
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Group B: 16-Week Usual CareExperimental Treatment1 Intervention
Participants will be allocated in a 1:1 ratio, using a permuted blocked design with varying block size. Study procedures will be conducted as follows: Testing visits at Week 1 and 18 for physical exams, physical fitness and function assessments, and survey questionnaires. Upon completion of post-intervention assessments, participants will have the option to take part in the 16-week HIIT exercise program.
Group II: Group A: 16-Week HIIT Exercise ProgramExperimental Treatment1 Intervention
Participants will be allocated in a 1:1 ratio, using a permuted blocked design with varying block size. Study procedures will be conducted as follows: Testing visits at Week 1, 9, and 19 for physical exams, physical fitness and function assessments, survey questionnaires, and cardiopulmonary fitness assessment. Virtual, aerobic training sessions three times weekly with trained oncology exercise specialist.

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,080 Previous Clinical Trials
340,862 Total Patients Enrolled
76 Trials studying Prostate Cancer
16,037 Patients Enrolled for Prostate Cancer
Prostate Cancer FoundationOTHER
47 Previous Clinical Trials
2,712 Total Patients Enrolled
27 Trials studying Prostate Cancer
1,862 Patients Enrolled for Prostate Cancer
Dong-Woo Kang, PhDPrincipal InvestigatorDana-Farber Cancer Institute
1 Previous Clinical Trials
40 Total Patients Enrolled

Media Library

High-Intensity Interval Training Exercise Program (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05918263 — N/A
Prostate Cancer Research Study Groups: Group A: 16-Week HIIT Exercise Program, Group B: 16-Week Usual Care
Prostate Cancer Clinical Trial 2023: High-Intensity Interval Training Exercise Program Highlights & Side Effects. Trial Name: NCT05918263 — N/A
High-Intensity Interval Training Exercise Program (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05918263 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research accepting applications for participants?

"Clinicaltrials.gov records state this medical trial is no longer welcoming candidates, as it was originally posted on December 1st 2023 and last updated June 23rd of the same year. However, 1325 other studies are still recruiting participants at present."

Answered by AI
~45 spots leftby Mar 2026